Fortrea Holdings (FTRE) Cash & Equivalents (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Cash & Equivalents came in at $168.6 million in Q2 2026, up 107.64% on a YoY basis from $81.2 million in Q2 2025, and up 14.31% quarter-over-quarter from $147.5 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Cash & Equivalents (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Cash & Equivalents for 5 consecutive years, with $168.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash & Equivalents rose 107.64% year-over-year to $168.6 million; the trailing twelve-month figure through Jun 2026 stood at $168.6 million (up 107.64% YoY), and the FY2025 full-year result was $174.6 million, up 47.34% from the prior year.
- Cash & Equivalents climbed to $168.6 million in Q2 2026 per FTRE's latest filing, from $147.5 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $174.6 million in Q4 2025 and bottomed at $81.2 million in Q2 2025.
- Historically, Cash & Equivalents has averaged $120.7 million across 5 years, with a median of $113.2 million in 2022.
- The sharpest annual moves came in 2025 and 2026: Cash & Equivalents plunged 35.66% in 2025, then jumped 107.64% in 2026.
- Over 5 years, Cash & Equivalents stood at $112.0 million in 2022, then declined by 3.04% to $108.6 million in 2023, then grew by 9.12% to $118.5 million in 2024, then soared by 47.34% to $174.6 million in 2025, then fell by 3.44% to $168.6 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $168.6 million, $147.5 million, and $174.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 1.91 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 502.69 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 192.03 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 928.39 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 168.60 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | 404.92 Mn |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 84.54 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 8.28 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 1.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 168.60 Mn |
| Mar 31, 2026 | 147.50 Mn |
| Dec 31, 2025 | 174.60 Mn |
| Sep 30, 2025 | 131.30 Mn |
| Jun 30, 2025 | 81.20 Mn |
| Mar 31, 2025 | 101.60 Mn |
| Dec 31, 2024 | 118.50 Mn |
| Sep 30, 2024 | 105.30 Mn |
| Jun 30, 2024 | 126.20 Mn |
| Mar 31, 2024 | 92.80 Mn |
| Dec 31, 2023 | 108.60 Mn |
| Sep 30, 2023 | 107.50 Mn |
| Jun 30, 2023 | 114.30 Mn |
| Dec 31, 2022 | 112.00 Mn |